EGFR and non-small cell lung carcinoma: Although previous studies have shown that de novo T790M mutation is associated with worse PFS and OS in patients with advanced EGFRm+ NSCLC treated with 1G EGFR‐TKIs,22, 23, 28 not all patients have exhibited no response to 1G EGFR‐TKIs.